Otri Allergy Aqueous Nasal Spray 0.05%

Nazione: Giordania

Lingua: inglese

Fonte: JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

Principio attivo:

Fluticasone Propionate 0.05 %

Commercializzato da:

مستودع أدوية سليمان طنوس وأولاده - Suleiman Tannous & Sons Co. Ltd

Codice ATC:

R01AD08

INN (Nome Internazionale):

Fluticasone Propionate 0.05 %

Dosaggio:

0.05%

Confezione:

120 Dose

Prodotto da:

Glaxo Wellcome (اسبانيا)

Dettagli prodotto:

5.77 :سعر الجمهور + الضريبة

Foglio illustrativo

OTRI ALLERGY
AQUEOUS NASAL SPRAY
(SUSPENSION)
DESCRIPTION:
Otri-Allergy Aqueous Nasal Spray is a nasal spray in the
form of suspension.
EACH SPRAY CONTAINS: 50 micrograms of Fluticasone
Propionate (0.05% w/w)
OTHER INGREDIENTS: Dextrose (anhydrous), Microcrystalline
cellulose & Sodium carboxymethylcellulose, Phenylethyl
alcohol, Benzalkonium chloride, Polysorbate 80, Dilute
hydrochloric acid and Purified water.
* Otri-Allergy Aqueous Nasal Spray is available in bottles
providing 120 & 60 metered doses.
WHAT IS OTRI-ALLERGY AQUEOUS NASAL SPRAY AND WHAT IS
IT USED FOR?
Otri-Allergy Aqueous Nasal Spray is indicated for the
prophylaxis and treatment of allergic rhinitis including
hay fever and that caused by other airborne allergens
such as house dust mite and animal dander.
This medicine also provides symptomatic relief of
sneezing, itchy and runny nose, itchy and watery eyes,
nasal congestion and associated sinus discomfort.
HOW TO TAKE OTRI-ALLERGY AQUEOUS NASAL SPRAY?
•
For administration by the intranasal route (nose) only.
•
Shake gently before use.
•
Do not exceed the recommended dose.
•
Before use the bottle needs to be primed by pumping
until a fine spray is produced.
ADULTS AGED 18 YEARS AND OVER:
Recommended Dose for the prophylaxis and treatment
of allergic rhinitis
•
Two sprays into each nostril once a day, preferably in
the morning.
•
In some cases two sprays into each nostril twice daily
may be required.
•
The Maximum daily dose should not exceed four
sprays into each nostril.
•
Once control is achieved, the dose should be titrated
down to one spray in each nostril once a day.
•
The minimum dose at which effective control of
symptoms is maintained should be used.
•
Prophylaxis of allergic rhinitis requires treatment
before contact with allergen.
•
For full therapeutic benefit regular usage is
recommended.
•
Maximum benefit may require 3-4 days of continuous
treatment in some people.
ELDERLY:
The normal adult dose should be used.
CHILDREN UNDER 18 YEARS OF AGE:
Should not be used